XML 12 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Current assets:    
Cash $ 15,828 $ 10,653
Trade accounts receivable, net of allowance for doubtful accounts of $332 and $317, respectively 18,712 21,054
Inventories, net 27,414 28,193
Prepaid expenses and other current assets 2,351 4,596
Total current assets 64,305 64,496
Property, plant and equipment, net 22,720 22,850
Goodwill 27,115 27,018
Other intangible assets, net 8,936 9,209
Deferred income taxes, net 11,459 11,836
Other noncurrent assets 1,985 2,292
Total Assets 136,520 137,701
Current Liabilities:    
Accounts payable 9,545 10,839
Current portion of long-term debt 624 1,361
Accrued compensation and related benefits 1,396 1,748
Accrued expenses and other current liabilities 3,966 4,758
Total current liabilities 15,531 18,706
Deferred income taxes 492 515
Other noncurrent liabilities 1,260 1,557
Total liabilities 17,283 20,778
Commitments and contingencies (Note 8)
Stockholders’ equity:    
Preferred stock – par value $.10 per share; authorized 1,000,000 shares; none issued 0 0
Common stock – par value $.10 per share; authorized 40,000,000 shares; issued – 20,474,676 shares at June 30, 2021 and 20,373,519 shares at December 31, 2020; outstanding – 16,051,707 shares at June 30, 2021 and 15,959,984 shares at December 31, 2020 2,047 2,037
Capital in excess of par value 186,138 185,464
Accumulated deficit (46,116) (47,598)
Accumulated other comprehensive loss (1,586) (1,782)
Treasury stock - at cost; 4,422,969 shares at June 30, 2021 and 4,413,535 shares at December 31, 2020 (21,388) (21,321)
Total Ultralife Corporation equity 119,095 116,800
Non-controlling interest 142 123
Total stockholders’ equity 119,237 116,923
Total liabilities and stockholders’ equity $ 136,520 $ 137,701